Torno Capital, LLC Eye Point Pharmaceuticals, Inc. Transaction History
Torno Capital, LLC
- $1.09 Trillion
- Q4 2024
A detailed history of Torno Capital, LLC transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Torno Capital, LLC holds 3,000 shares of EYPT stock, worth $19,740. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,000Holding current value
$19,740% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding EYPT
# of Institutions
156Shares Held
72.4MCall Options Held
187KPut Options Held
225K-
Cormorant Asset Management, LP Boston, MA8.33MShares$54.8 Million4.9% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.78MShares$44.6 Million2.1% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.75MShares$37.8 Million0.08% of portfolio
-
Franklin Resources Inc San Mateo, CA4.14MShares$27.2 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.8MShares$25 Million0.0% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $224M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...